Evogene Financials - Benzinga

Evogene Ltd

EVGNNASDAQ

Trade with Public

Trade with Public

$0.4100

0.037.89%

近くで: Sep 28, 5:00 PM EST

$0.4011

0.02115.55%

プレマーケット: 9:12 AM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

Evogene Financials

Evogene (EVGN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
CORRECTION: Evogene Q2 EPS $(0.13) Beats $(0.27) Estimate, Sales $347.000K Beat $325.000K Estimate

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51.85 percent. This is a 74 percent increase over losses of $(0.50) per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 20, 2026

Benzinga Insights

PRO
Evogene Q1 EPS $(0.60) Misses $(0.27) Estimate, Sales $334.000K Miss $350.000K Estimate

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.27) by 122.22 percent. This is a 57.89 percent decrease over losses of $(0.38) per share from the

Benzinga Newsdesk

Evogene Earnings Review: Q4 Summary

Benzinga Insights

PRO
Evogene Q4 EPS $(0.61) Misses $(0.26) Estimate, Sales $314.000K Beat $275.000K Estimate

Benzinga Newsdesk

Earnings Scheduled For March 5, 2026

Benzinga Insights

© 2026 Benzinga | All Rights Reserved